Acetazolamide - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for acetazolamide and what is the scope of freedom to operate?

Acetazolamide is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Alembic, Cadila, Heritage Pharma, Indicus Pharma, Micro Labs Ltd India, Nostrum Labs Inc, Novast Labs, Rising, Teva Branded Pharm, Ajanta Pharma Ltd, Alra, Appco, Ascot, Breckenridge, Chartwell Molecular, Epic Pharma Llc, Hibrow Hlthcare, Mankind Pharma, Ne Rx Pharma, Novitium Pharma, Rubicon, Strides Pharma, Sun Pharm Industries, Taro, Torrent, Vangard, Watson Labs, Zydus Lifesciences, Avet Lifesciences, Endo Operations, Hikma, Hospira, Mylan Asi, Xgen Pharms, Zydus Pharms, and Teva Womens, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for acetazolamide. Thirty-three suppliers are listed for this compound.

Summary for acetazolamide

US Patents:	0
Tradenames:	3
Applicants:	37
NDAs:	40
Drug Master File Entries:	10
Finished Product Suppliers / Packagers:	33
Raw Ingredient (Bulk) Api Vendors:	125
Clinical Trials:	147
Patent Applications:	7,148
Drug Prices:	Drug price trends for acetazolamide
What excipients (inactive ingredients) are in acetazolamide?	acetazolamide excipients list
DailyMed Link:	acetazolamide at DailyMed

See drug prices for acetazolamide

Recent Clinical Trials for acetazolamide

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Incannex Healthcare Ltd	Phase 2/Phase 3
Johannes Grand	Phase 4
University of Arizona	Early Phase 1

See all acetazolamide clinical trials

Pharmacology for acetazolamide

Drug Class	Carbonic Anhydrase Inhibitor
Mechanism of Action	Carbonic Anhydrase Inhibitors

Medical Subject Heading (MeSH) Categories for acetazolamide

Anticonvulsants
Carbonic Anhydrase Inhibitors
Diuretics

Anatomical Therapeutic Chemical (ATC) Classes for acetazolamide

S01EC	Carbonic anhydrase inhibitors
S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for acetazolamide

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	DIAMOX	acetazolamide	CAPSULE, EXTENDED RELEASE;ORAL	012945-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Vangard	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	087654-001	Feb 5, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Torrent	ACETAZOLAMIDE	acetazolamide	TABLET;ORAL	213706-002	Jan 26, 2024		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.